Ware, United Kingdom

John Bradshaw

This inventor holds 40 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Glaxo Group Limited, Allen Hanburys Limited, Allen & Hansbury, Limited. Active years: 1978-1996.


% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 10

Forward Citations = 362(Granted Patents)


Location History:

  • Dane End, near Ware, GB (1982)
  • Hertfordshire, GB (1984 - 1987)
  • Royston, GB (1989 - 1993)
  • Ware, GB (1978 - 1996)

Company Filing History:


Years Active: 1978-1996

Loading Chart...
Areas of Expertise:
Benzanilide Derivatives
Tricyclic Ketones
Heterocyclic Compounds
Triazole Derivatives
Aminocyclopentane Esters
Pharmaceutical Formulations
Histamine Antagonists
Aminoalkyl Compounds
Furan Derivatives
Prostanoid Compounds
Pharmacologically Active Compounds
Thiophene Derivatives
40 patents (USPTO):Explore Patents

Title: John Bradshaw - Pioneering Inventor from Ware, GB

Introduction: John Bradshaw is a renowned inventor hailing from Ware, GB, known for his groundbreaking contributions to various industries.

Latest Patents: John Bradshaw holds several patents in the fields of technology, healthcare, and sustainable energy, showcasing his diverse range of innovative ideas.

Career Highlights: Throughout his illustrious career, John Bradshaw has been recognized for his ability to transform creative concepts into tangible inventions that have revolutionized the way we live and work.

Collaborations: John Bradshaw has collaborated with leading research institutions, universities, and companies worldwide to further develop his inventions and bring them to the market, solidifying his reputation as a visionary inventor.

Conclusion: John Bradshaw's passion for innovation and his relentless pursuit of excellence have cemented his legacy as a pioneering inventor whose work continues to inspire future generations in the world of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…